Veröffentlichungen
Publikationsliste 2019
Seliger, C., Luber, C., Gerken, M., Schaertl, J., Proescholdt, M., Riemenschneider, M.J., Meier, C.R., Bogdahn, U., Leitzmann, M.F., Klinkhammer-Schalke, M., Hau, P., 2019b. Use of metformin and survival of patients with high-grade glioma. Int. J. Cancer 144, 273–280.
Taubenhansl, C., Ortmann, O., Gerken, M., Inwald, E.C., Klinkhammer-Schalke, M., 2019. Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients. Arch Gynecol Obstet 301, 573–583.
Teufel, A., Furst, A., Gerken, M., Hohenthanner, I., Klinkhammer-Schalke, M., 2019. Benefit of adjuvant chemotherapy in patients with high-risk UICC II colon cancer T4N0M0: A ten-year population based analysis of 3544 cases. J. Clin. Oncol. 37.
Voekel, V., Draeger, T., Gerken, M., Fuerst, A., Klinkhammer-Schalke, M., 2019. Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals? Gesundheitswesen 81, 801–807.
Voelkel, V., Draeger, T., Gerken, M., 2019a. Long-term Survival of Patients with Colon Cancer and Rectal Cancer: A Comparison of Colorectal Cancer Centers and non-certified Hospitals (2018). Gesundheitswesen 81, E208–E208.
Voelkel, Vinzenz, Draeger, T., Groothuis-Oudshoorn, C.G.M., de Munck, L., Hueting, T., Gerken, M., Klinkhammer-Schalke, M., Lavric, M., Siesling, S., 2019a. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J. Cancer Res. Clin. Oncol. 145, 1823–1833.
Voelkel, Vinzenz, Draeger, T., Schnitzbauer, V., Gerken, M., Benz, S., Klinkhammer-Schalke, M., Fuerst, A., 2019b. Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection. EJSO 45, 1607–1612.
Voelkel, V., Draeger, T., Siesling, S., Groothuis-Oudshoorn, K., 2019b. Influence 2.0: A Time-Dependent Model to Predict Locoregional Recurrence and Second Primaries in Early Breast Cancer Patients. Value Health 22, S517–S517.
Wimmer, T., Ortmann, O., Gerken, M., Klinkhammer-Schalke, M., Koelbl, O., Inwald, E.C., 2019. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch. Gynecol. Obstet. 299, 1131–1140.
Draeger, T., Voelkel, V., Schnitzbauer, V., Gerken, M., Benz, S., Klinkhammer-Schalke, M., Fuerst, A., 2019. Laparoscopic and open resection of rectal canceris age an effect modifier for short- and long-term survival? Int. J. Colorectal Dis. 34, 821–828.
Fiedler, M., Renner, P., Schubert, J., Weber, F., Hartmann, A., Iro, H., Vielsmeier, V., Bohr, C., Gerken, M., Reichert, T.E., Ettl, T., 2019. Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study. Clin. Oral Investig. 23, 3801–3809.
Finke, I., Behrens, G., Schwettmann, L., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., Jansen, L., 2019. Socioeconomic Differences and Lung Cancer Survival in Germany: Differences in Cancer Therapy and Clinical Prognostic Factors. J. Epidemiol. Community Health 73, A77–A77.
Ortmann, O., Torode, J., Harrison, C., Bruns, J., Helbig, U., Philippou, N., Schreck, S., Albreht, T., Borras, J., Coebergh, J.-W., Hochhaus, A., Klinkhammer-Schalke, M., Kowalski, C., Landenberger, M., Mugele, K., Rambach, R., 2019. Research driving innovation: what are key factors for successful integration of translational science into oncology care concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin, Germany. J. Cancer Res. Clin. Oncol. 145, 1521–1525.
Papathemelis, T., Knobloch, S., Gerken, M., Scharl, A., Anapolski, M., Ignatov, A., Inwald, E.C., Ortmann, O., Scharl, S., Klinkhammer-Schalke, M., 2019. Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. J. Cancer Res. Clin. Oncol. 145, 1369–1376.
Pukrop, T., Windschuettl, S., Lindberg-Scharf, P., Heudobler, D., Herr, W., Andreesen, R., Klinkhammer-Schalke, M., Koller, M., 2019. Development of a screening method for the assessment and improvement of the needs and quality of life of oncological patients in the daily routine. Oncol. Res. Treat. 42, 180–180.
Schmitt, J., Klinkhammer-Schalke, M., 2019. Health Care Researchers take Responsibility. Gesundheitswesen 81, 789–790.
Schnitzbauer, V., Gerken, M., Benz, S., Völkel, V., Draeger, T., Fürst, A., Klinkhammer-Schalke, M., 2019. Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort. Surg Endosc 34, 1132–1141.
Seliger, C., Gerken, M., Leitzmann, M.F., Hau, P., 2019a. Reply to Lu: Connecting the dots between metformin and high-grade glioma. Int. J. Cancer 144, 1756–1757.